Skip to content

Fetal brain development following prevention of mother-to-child HIV transmission: a multi-modal MR study

Fetal brain development following prevention of mother-to-child HIV transmission: a multi-modal MR study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035706
Enrollment
Unknown
Registered
2020-08-16
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

human immunodeficiency virus

Interventions

HIV positive:None
HIV negative:None

Sponsors

Shanghai Public Health Clinical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: The participants in the current study need to be: (1) a pregnant women with singleton pregnancy in the third trimester and gestational age of 28 weeks or more; (2) a Han Chinese, aged 18 to 40 years old; (3) willing to participate in the follow-up study, and sign an informed consent. The HIV-infected pregnant women in the experimental group need to further meet: (1) a positive medical test or positive confirmation from ELISA test; (2) receiving regular prevention of mother-to-child HIV transmission; (3)normal clinical biochemical indicators (CD4 count, CD4/CD8 ratio) during the whole pregnancy.

Exclusion criteria

Exclusion criteria: (1) With serious pregnancy complications such as high blood pressure, placenta previa, and abnormal fetal position; (2) With intracranial viral infection other than HIV; (3) With history of central nervous system disease such as intracranial tumor, head injury, and cerebrovascular disease; (4) With history of chronic mental illness such as depression and anxiety; (5) With history of substance abuse or dependence on alcohol and drugs; (6) With contraindication to MRI.

Design outcomes

Primary

MeasureTime frame
brain volume;

Countries

China

Contacts

Public ContactDan-Chao Cai

Shanghai Public Health Clinical Center

caidanchao@shphc.org.cn+86 21 37990333-7203

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026